These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33570257)

  • 1. Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research).
    Thébaud B; Lalu M; Renesme L; van Katwyk S; Presseau J; Thavorn K; Cobey KD; Hutton B; Moher D; Soll RF; Fergusson D
    Stem Cells Transl Med; 2021 Jul; 10(7):968-975. PubMed ID: 33570257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell-based therapies in neonatology: a new hope.
    Thébaud B
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F583-F588. PubMed ID: 29973349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell therapies for neonatal lung diseases: Are we there yet?
    Thébaud B
    Semin Perinatol; 2023 Apr; 47(3):151724. PubMed ID: 36967368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity.
    Thébaud B
    Am J Perinatol; 2018 May; 35(6):566-569. PubMed ID: 29694998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based therapy for bronchopulmonary dysplasia in preterm infants
    Guillot M; Offringa M; Lacaze-Masmonteil T; Thébaud B
    Can J Physiol Pharmacol; 2019 Mar; 97(3):232-234. PubMed ID: 30290122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based therapies for neonatal lung disease.
    O'Reilly M; Thébaud B
    Cell Tissue Res; 2017 Mar; 367(3):737-745. PubMed ID: 27770256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation.
    Lesage F; Thébaud B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.
    Augustine S; Cheng W; Avey MT; Chan ML; Lingappa SMC; Hutton B; Thébaud B
    Stem Cells Transl Med; 2020 Feb; 9(2):158-168. PubMed ID: 31746123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils.
    Möbius MA; Thébaud B
    Paediatr Respir Rev; 2016 Sep; 20():33-41. PubMed ID: 27425012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model.
    Lithopoulos MA; Strueby L; O'Reilly M; Zhong S; Möbius MA; Eaton F; Fung M; Hurskainen M; Cyr-Depauw C; Suen C; Xu L; Collins JJP; Vadivel A; Stewart DJ; Burger D; Thébaud B
    Am J Respir Crit Care Med; 2022 May; 205(10):1186-1201. PubMed ID: 35286238
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development.
    Kramer BW; Abman S; Daly M; Jobe AH; Niklas V
    Paediatr Respir Rev; 2023 Dec; 48():24-29. PubMed ID: 37268507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges.
    Chang YS; Ahn SY; Sung S; Park WS
    Yonsei Med J; 2017 Mar; 58(2):266-271. PubMed ID: 28120555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders.
    Chang YS; Yang M; Ahn SY; Sung SI; Park WS
    Stem Cells Transl Med; 2024 Oct; 13(10):941-948. PubMed ID: 39120439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.